- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/14
Total number of patents in this class: 1583
10-year publication summary
108
|
97
|
110
|
119
|
124
|
123
|
147
|
133
|
108
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Abbvie Inc. | 1783 |
63 |
Intra-Cellular Therapies, Inc. | 393 |
42 |
Pharmacosmos A/S | 69 |
38 |
Pharmacosmos Holding A/S | 185 |
38 |
Merck Patent GmbH | 5845 |
34 |
Novartis AG | 11276 |
28 |
Agenebio, Inc. | 43 |
27 |
Idemitsu Kosan Co., Ltd. | 4103 |
25 |
Achillion Pharmaceuticals, Inc. | 168 |
23 |
Dana-Farber Cancer Institute, Inc. | 2536 |
21 |
G1 Therapeutics, Inc. | 67 |
21 |
Genentech, Inc. | 3867 |
20 |
Bristol-myers Squibb Company | 4865 |
19 |
Bayer Pharma AG | 1085 |
18 |
Duk San Neolux Co., Ltd. | 589 |
15 |
Samsung Display Co., Ltd. | 32745 |
14 |
Bayer AG | 3208 |
14 |
The Board of Trustees of the Leland Stanford Junior University | 6239 |
14 |
Merck Sharp & Dohme LLC | 3746 |
14 |
LG Chem, Ltd. | 17637 |
13 |
Other owners | 1082 |